IDEX Corporation (IEX) Presents at Citi's Global Industrial Tech & Mobility Conference 2026 Transcript
IEX beats Q4 estimates as sales rose 4% and margins expand, while 2026 earnings guidance calls for continued organic growth.
IDEX Corporation (IEX) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Idex (IEX) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Idex (IEX) came out with quarterly earnings of $2.1 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings of $2.04 per share a year ago.
IEX heads into Q4 earnings with steady EPS estimates, modest revenue growth outlook, strong HST momentum and FSDP softness ahead.
IDEX Corp.: Q4 Earnings Are Coming Up Quick, Look For Signs Of Growth
Idex (IEX) reported earnings 30 days ago. What's next for the stock?
IEX gains from strong FMT and HST momentum, strategic acquisitions and enhanced shareholder returns despite FSDP softness.
IDEX Corporation ( IEX ) Q3 2025 Earnings Call October 29, 2025 9:00 AM EDT Company Participants James Giannakouros - Vice President of Investor Relations Eric Ashleman - CEO, President & Director Akhil Mahendra - Interim CFO & VP of Corporate Development Conference Call Participants Deane Dray - RBC Capital Markets, Research Division Michael Halloran - Robert W. Baird & Co. Incorporated, Research Division Joseph Giordano - TD Cowen, Research Division Nathan Jones - Stifel, Nicolaus & Company, Incorporated, Research Division Bryan Blair - Oppenheimer & Co. Inc., Research Division Vladimir Bystricky - Citigroup Inc., Research Division Robert Jamieson - Vertical Research Partners, LLC Walter Liptak - Seaport Research Partners Brett Linzey - Mizuho Securities USA LLC, Research Division Presentation Operator Greetings, and welcome to the Third Quarter 2025 IDEX Corporation Earnings Conference Call.
IEX's Q3 earnings and revenues top estimates, driven by strong gains in Health & Science Technologies and solid margin growth.
While the top- and bottom-line numbers for Idex (IEX) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.